- Meeting abstract
- Open Access
Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
© Dalmau et al. 2015
- Published: 16 December 2015
- Coronary Artery Bypass Grafting
- Compute Tomography Angiography
- Adverse Cardiac Event
Prevalence of graft occlusion is high after coronary artery bypass grafting (CABG). Routine use of aspirin after CABG reduces graft failure and ischemic complications. The benefit of concomitant clopidogrel administration remains a controversial issue.
We sought to evaluate the impact of use aspirin plus clopidogrel versus aspirin alone on graft patency and adverse cardiovascular events 18 months after CABG.
In this single-centre prospective randomized study, 200 consecutive patients undergoing elective CABG were randomly assigned to two groups: 97 patients received aspirin 300 mg (A) and 103 patients received aspirin 100 mg plus clopidogrel 75 mg (AC). Antiplatelet protocol was initiated immediately after surgery and continued daily for one year. Graft patency was evaluated by multislice computed tomography angiography (MSCT) 18 months after surgery. The occurrence of major cardiac or cerebrovascular adverse events (MACCE) and bleeding complications during follow-up were assessed.
Preoperative patient characteristics were similar in both groups. MSCT graft patency was assessed in 194 patients (97%). A total of 542 grafts and 680 distal anastomoses were analyzed. Overall graft patency was 83.1% in group A and 89.4% in the AC group (p = 0.04). Patency rates in the A group versus AC group were similar: Left internal mammary artery (95.9% vs. 95.1%, p = 0.85), right internal mammary artery (97.8% vs. 91.2%, p = 0.37), radial artery (74.2% vs. 92.6%, p = 0.06), saphenous vein graft (78.6% vs. 83.5%, p = 0.45). Clinical follow-up was complete in 200 patients. The incidence of MACCEs was similar in both groups (A 5.2% vs. AC 9.7%, p = 0.22). The need for percutaneous coronary re-intervention showed no statistically significant differences (A 3.1% vs. AC 4.9%, p = 0.78).
Compared with aspirin monotherapy, the combination of aspirin plus clopidogrel following CABG did not significantly increase graft patency or reduce the incidence of adverse cardiac events.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.